Building Trust Across the Pharmaceutical Supply Chain: A Reference Architecture for End-to-End Traceability

RA-001 uses a vendor-neutral systems-analysis methodology. The research reviews primary regulatory material, industry standards, pharmaceutical serialization practices, enterprise-system boundaries, logistics handovers, and verification mechanisms across selected U.S., European Union, and Indian contexts. The analysis distinguishes regulatory requirements from industry implementation patterns and from architectural recommendations proposed by KryoNex Research.

Pharmaceutical traceability has evolved from paper-based and organization-specific records toward increasingly electronic and interoperable systems. However, implementations continue to span independently governed enterprise platforms, trading-partner interfaces, regulatory repositories, and physical logistics processes. The challenge becomes managing the heterogeneity and integration boundary conditions across these distinct zones, rather than assuming standard end-to-end integration or uniform data models.

Pharmaceutical traceability is not a single, globally integrated technology stack. Instead, relevant information is created, maintained, exchanged, and verified across multiple independently governed environments (F02). These environments include product and logistics-unit identification; serialization and aggregation systems; MES, ERP, WMS, TMS and serialization repositories; GS1 EPCIS / CBV event exchange; trading-partner interfaces and verification mechanisms; dispensing and endpoint systems; and jurisdiction-specific regulatory or partner ecosystems (such as US DSCSA ATP lookup, EU EMVS spokes, and Indian CDSCO domestic/export portals, including historical DAVA configurations [16] transitioned under the withdrawal of Para 2.76 of the Handbook of Procedures 2023 by DGFT Public Notice No. 44/2024-25-DGFT [6]).

These components can interoperate while retaining separate ownership, governance, authority, and system-of-record responsibilities.

The architectural significance of F02 is therefore not that existing traceability infrastructure is absent. Substantial infrastructure already exists. The relevant question is where assurance must cross organizational, physical, identity, observation, or system boundaries.

F03 introduces the principle “Boundary ≠ Failure.”

A boundary identifies a transition at which assurance may depend on evidence, controls, reconciliation, authorization, correlation or governance. The existence of a boundary does not itself demonstrate a control failure or traceability weakness.

Preserve these four assurance questions: - Product Identity — Is sufficient confidence established that the physical product corresponds to the digital identifier being used? - Event Integrity — Can the origin, sequence, timing and representation integrity of a digital traceability event be assessed? Digital-record integrity must not automatically be presented as proof that the represented physical event occurred exactly as recorded. - Organizational Authority — Can the participating organization be identified and can its relevant authorization or status be evaluated for the applicable interaction? - Observation Correlation — Can an environmental or logistics observation be associated with the relevant product, logistics unit, event, location, time interval or custody period at the granularity required by the use case?

Preserve these three recurring boundary patterns: physical possession versus legal/transactional responsibility; heterogeneous regulatory/implementation state; endpoint verification and lifecycle closure.

F03 must remain vendor-neutral and non-prescriptive. Do not establish blockchain, DLT, credentials, IoT or another technology as the required solution.

The proposed reference architecture defines a vendor-neutral logical framework where existing operational and regulatory systems remain authoritative, while boundary-assurance capabilities strengthen cross-organizational verification without requiring replacement of those systems (F04).

The logical architecture comprises six distinct layers: 1. Physical Pharmaceutical Supply Chain 2. Identification & Observation 3. Authoritative Operational Systems 4. Traceability Semantics & Exchange 5. Boundary Assurance Capabilities 6. Regulatory & Partner Ecosystems

Boundary Assurance Dimensions Boundary Assurance Capabilities operate as decoupled logical functions addressing four core dimensions: * Product Identity: Verifying that the physical product units and packaging features correspond to the digital identifiers (e.g., serial numbers, GTINs) without requiring a centralized registry. * Event Integrity: Evaluating the origin, timing, and sequence of digital traceability events. (Note: Event integrity does not establish physical truth, meaning digital-record integrity does not automatically prove that the represented physical event occurred exactly as recorded). * Organizational Authority: Evaluating the identity, credential status, and role authorization of the participating partner (Note: Credential verification does not equal transaction authorization). * Observation Correlation: Associating physical environmental telemetry (e.g., temperature logs) with product identifiers, event timestamps, or custody intervals.

Cross-Cutting Controls * Evidence Protection: Ensuring that traceability assertions, signatures, and exchange logs are protected against tampering or retroactive modification. * Trust & Lifecycle Governance: Rules governing key management, identity credential lifecycles, and policy reconciliation across trading networks.

Operational Outcomes The assurance architecture is designed to support normal supply-chain workflows (e.g., receiving, shipping, and dispensing) as well as exception, reconciliation, investigation, or quarantine processes where suspect or damaged product alerts are triggered.

Technology & Shared Ledger Constraints Decentralized ledger technology (DLT) is not a mandatory or default layer of this reference architecture. Shared-ledger mechanisms may only be described as conditional candidates where independently governed shared state is justified after considering governance, privacy, latency, complexity, and operational requirements.

Important Architectural Distinctions To prevent security misinterpretations, the architecture maintains explicit boundaries between physical states and digital assertions: * Event integrity does not establish physical truth: A validated cryptographic event record does not prove the physical container was loaded or handled correctly. * Credential verification does not equal transaction authorization: Confirming that a partner is an Authorized Trading Partner (ATP) does not authorize them to execute specific transactions. * Device identity does not establish calibration: Verifying the cryptographic signature of an IoT temperature sensor does not prove the sensor is calibrated or functioning correctly. * Immutability does not establish correctness: Storing an incorrect or fraudulent serialization record in an immutable log does not make the record correct. * EPCIS provides traceability semantics but does not itself establish trust: While EPCIS provides the semantic structure for event exchange, the trust in every underlying assertion must be verified at the boundary. * Authoritative data ownership remains with the appropriate operational or regulatory system: No global, centralized database holds custody of the end-to-end supply chain data; each entity retains ownership of its system of record.